Medicare Program: Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
CMS-2026-2080-0001NPRM
Comments
25
Last activity Jul 30, 2026
Deadline
9 days
Closes Aug 18, 2026
Net supportiSupport minus oppose · campaigns included
+70%
+70% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Medicare Program: Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
- Posted
- Jun 16, 2026
- Comment period
- Jun 16, 2026 – Aug 18, 2026
- FR Doc
- 2026-12059
- CFR
- 42 CFR Parts 423 and 429
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Analyzed 20 of 25 comments
80%· analysis in progress
Stance breakdown
+70%
Net support
Support17Oppose3Not yet analyzed5
Aggregates include form-letter campaigns. Excluding them, net support is +70% across organic comments.
Who commented
Breakdown by commenter type.
Academic
1
Individual
15
Trade association
1
Advocacy
1
Other
2
Not yet analyzed
5
Comments over time
Weekly arrivals, stacked by stance.
Posted Jun 16, 2026Deadline Aug 18, 2026
Jun 15Jun 22Jun 29Jul 13Jul 20Jul 27
Support17Oppose3Other0
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
93%
7%
0%
Other
50%
50%
0%
Academic
100%
0%
0%
Trade association
100%
0%
0%
Advocacy
0%
100%
0%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Medication affordability9
Innovation in treatment delivery2
Medication supply chain and availability2
Data collection requirements1
Fixed-combination aggregation1
Impact on drug r&d1
Medicaid access and provider participation1
Reinvesting negotiation savings1
Transparency of negotiation-eligible drugs1
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.